1.
两组胸腺瘤患者基本情况比较
Patients' characteristics
| MG(n =421) | Non-MG(n=1, 429) | P | |
| MG: myasthenia gravis; WHO: World Health Organization. 注：本表得到版权所有者©2011-2016 Journal of Thoracic Disease复制许可。 | |||
| Gender | 0.034 | ||
| Male | 206 (48.9%) | 782 (54.7%) | |
| Female | 215 (51.1%) | 647 (45.3%) | |
| Age (mean, yr) | 49 | 52 | < 0.001 |
| Overall survival | 95.95% | 92.29% | 0.026 |
| WHO Classification | < 0.001 | ||
| A | 18 (4.3%) | 89 (6.2%) | |
| AB | 80 (19.0%) | 356(24.9%) | |
| B1 | 68 (16.2%) | 164(11.5%) | |
| B2 | 128 (30.4%) | 169 (11.8%) | |
| B3 | 107 (25.4%) | 256 (17.9%) | |
| C | 19 (4.5%) | 351(24.6%) | |
| Carcinoid | 1(0.2%) | 44 (3.1%) | |
| WHO classification | < 0.001 | ||
| Type A thymoma | 18 (4.3%) | 89 (6.2%) | |
| Type B (including AB) thymoma | 383 (91.0%) | 945 (66.1%) | |
| Thymic cancer | 20 (4.8%) | 395 (27.6%) | |
| Thymectomy | < 0.001 | ||
| Incomplete | 37 (8.8%) | 412(29.0%) | |
| Complete | 382 (91.2%) | 1, 008 (71.0%) | |
| Tumor size (cm) | 5.6 | 7.2 | < 0.001 |
| Masaoka staging | 0.004 | ||
| Ⅰ | 196 (46.6%) | 547 (38.3%) | |
| Ⅱ | 83 (19.7%) | 277 (19.4%) | |
| Ⅲ | 116 (27.6%) | 458 (32.1%) | |
| Ⅳ | 26 (6.2%) | 147(10.3%) | |
| Chemotherapy (given) | 36(8.8%) | 317 (23.4%) | ＜0.001 |
| Radiotherapy (given) | 167 (41.0%) | 636 (47.1%) | 0.031 |
| Resectability (rate of R0 resection) | 379 (90.0%) | 1, 212 (85.1%) | 0.009 |